Rufini, Vittoria
 Distribuzione geografica
Continente #
EU - Europa 6.851
NA - Nord America 5.857
AS - Asia 2.606
SA - Sud America 421
AF - Africa 43
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.796
Nazione #
US - Stati Uniti d'America 5.786
DE - Germania 2.839
CN - Cina 1.078
SE - Svezia 953
SG - Singapore 863
IT - Italia 573
UA - Ucraina 553
BR - Brasile 392
PL - Polonia 373
FR - Francia 337
GB - Regno Unito 305
IE - Irlanda 280
FI - Finlandia 252
IN - India 200
ID - Indonesia 168
RU - Federazione Russa 131
TR - Turchia 84
BE - Belgio 50
CA - Canada 44
NL - Olanda 42
JP - Giappone 30
AT - Austria 29
KR - Corea 26
VN - Vietnam 26
CH - Svizzera 24
CI - Costa d'Avorio 21
ES - Italia 21
IR - Iran 18
HK - Hong Kong 16
MX - Messico 15
LT - Lituania 14
AR - Argentina 13
AU - Australia 12
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 10
DK - Danimarca 10
PK - Pakistan 10
BD - Bangladesh 9
PH - Filippine 9
AZ - Azerbaigian 8
PT - Portogallo 8
ZA - Sudafrica 8
HU - Ungheria 7
AL - Albania 6
GR - Grecia 6
IL - Israele 6
IQ - Iraq 6
DZ - Algeria 5
LK - Sri Lanka 5
MA - Marocco 5
RO - Romania 5
KZ - Kazakistan 4
MY - Malesia 4
OM - Oman 4
PE - Perù 4
CL - Cile 3
EE - Estonia 3
JO - Giordania 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CO - Colombia 2
CR - Costa Rica 2
CU - Cuba 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
IM - Isola di Man 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
EC - Ecuador 1
KE - Kenya 1
KW - Kuwait 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
QA - Qatar 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 15.796
Città #
Chandler 1.273
Singapore 492
Ashburn 411
Warsaw 338
Jacksonville 335
Dublin 276
San Mateo 257
Ann Arbor 230
Nanjing 222
Nürnberg 199
Munich 188
Jakarta 164
Wilmington 160
Dearborn 156
New York 138
Helsinki 129
Woodbridge 121
Boston 117
Milan 117
Houston 114
Fairfield 110
Rome 105
Cattolica 92
Marseille 92
Nanchang 89
Seattle 85
Bremen 83
Los Angeles 80
Moscow 75
Lawrence 74
Redwood City 73
Izmir 68
Princeton 67
The Dalles 63
Zhengzhou 63
Lancaster 62
Beijing 61
Hyderabad 61
Hefei 52
Redmond 52
Boardman 50
Hebei 48
Brussels 47
Kunming 41
Chicago 40
Frankfurt am Main 40
Mountain View 38
Shanghai 32
Changsha 31
Cambridge 30
Tianjin 30
Guangzhou 28
Leawood 28
Shenyang 28
Jiaxing 27
Toronto 27
Seoul 26
São Paulo 26
University Park 26
Detroit 24
Norwalk 22
Pune 22
Abidjan 21
Düsseldorf 21
London 21
Fremont 20
Jinan 20
Nuremberg 20
Kraków 19
Phoenix 17
Columbus 16
Hangzhou 15
Santa Clara 15
Belo Horizonte 14
Vienna 14
Augusta 13
Brasília 13
Falkenstein 13
Falls Church 13
Hanoi 13
Rio de Janeiro 13
Amsterdam 12
Hong Kong 12
North Bergen 12
Bexley 11
San Francisco 11
Tokyo 11
Zurich 11
Chengdu 10
Lanzhou 10
Ottawa 10
Palermo 10
Renton 10
Andover 9
Edinburgh 9
Mexico City 9
Paris 9
San Diego 9
Wuhan 9
Atlanta 8
Totale 8.158
Nome #
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 312
Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer 297
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 245
18F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports 237
Markedly Increased 18F-FDG Uptake in a Nonfunctioning Adrenal Adenoma Mimicking Malignancy 235
Incidentally discovered adrenal masses: a functional and morphological study 218
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 217
A phase II study of sunitinib in advanced hepatocellular carcinoma 214
Renal artery stenting in patients with chronic ischemic heart disease 190
[Contribution of nuclear medicine to the diagnosis of silent adrenal masses] 177
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors 175
Are the simplified methods to estimate Ki in 18F-FDG PET studies feasible in clinical routine? Comparison between three simplified methods. 173
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 171
A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features. 168
Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. 166
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 166
Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer 151
A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome Caused by a Metastatic Neuroendocrine Tumor of the Pancreas Detected by 68Ga-DOTANOC and 18F-FDG PET/CT 144
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 143
A NEW APPROACH IN THE TREATMENT OF STAGE-IV NEUROBLASTOMA USING A OMBINATION OF {[I-131] METAIODOBENZYLGUANIDINE (MIBG) AND CISPLATIN} 139
Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor 138
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 137
Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography 137
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 136
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study 134
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 134
Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of (131) I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen. 133
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. 131
Diagnostic imaging of euthyroid goiter 131
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature 130
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. 130
Cardiac metastases of Ewing sarcoma detected by 18F-FDG PET/CT 129
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study 123
Cushing's syndrome due to a bronchial ACTH-secreting carcinoid successfully treated with radio frequency ablation (RFA) 121
Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. 120
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography 120
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 119
Physiological Activity of Spinal Cord in Children: An 18F-FDG PET-CT Study 119
imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls 119
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). 118
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 116
Imaging techniques for the evaluation of cervical cancer 116
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 115
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 115
Taralli S, Sollini M, Milella M, Perotti G, Filice A, Menga M, Versari A, Rufini V. (18)F-FDG and (68)Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study. 115
Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine 114
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 114
Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma 113
Diagnostic imaging in thyrotoxicosis 112
Role of PET/CT in the functional imaging of endocrine pancreatic tumors 110
Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice? 110
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid 110
Diagnostic imaging of the thyroid: metodology and norma patterns 109
Lung uptake of fluorine-18 fluoroethyl-choline PET-CT in patients with prostate cancer 109
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 108
Masking effect of chronic pancreatitis in the interpretation of somatostatin receptor positron emission tomography in pancreatic neuroendocrine tumors. 107
Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature 107
(18)F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review 104
Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns 103
A Rare Case of Solitary Fibrous Tumor of the Adrenal Gland Detected by 18F-FDG PET/CT 103
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 103
The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review 102
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma 102
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 100
Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma 100
Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma 100
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 100
A rare case of synchronous bilateral pulmonary neuroendocrine tumor detected by 68Ga-DOTANOC PET/CT 99
Thyrotoxicosis due to ectopic retrotracheal adenoma treated with radioiodine 99
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma 99
A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancer 99
Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma 98
(18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome 97
Unusual increased metaiodobenzylguanidine uptake in liposarcoma 94
CRITICAL OBSERVATIONS ON NEUROBLASTOMA TREATMENT WITH 131-I-METAIODOBENZYLGUANIDINE AT DIAGNOSIS 94
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 94
Multifocal Extra-Adrenal Paraganglioma Evaluated With Different PET Tracers: Comparison Between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT 94
Radiolabeled mataiodobenzylguanidine in the diagnosis of neural crest tumors 92
Diagnostic performance of (18)F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis 92
Which imaging technique should we use in the follow up of gynaecological cancer? 92
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study 92
I-131 METAIODOBENZYLGUANIDINE IN THE TREATMENT OF NEUROBLASTOMA AT DIAGNOSIS 91
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 91
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumors: a meta-analysis 90
Intrapancreatic Accessory Spleen Detected by 68Ga DOTANOC PET/CT and 99mTc-Colloid SPECT/CT Scintigraphy 90
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 89
A rare case of solitary fibrous tumor of the adrenal gland detected by (18)F-FDG PET/CT 89
Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up 88
Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission Tomography: A Meta-analysis 87
68Ga-DOTATOC PET/CT in Pleural Solitary Fibrous Tumors 87
Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls 86
Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team 86
An unusual case of adrenal metastasis from colorectal cancer: computed tomography and fluorine 18-fluoro-deoxy-glucose positron emission tomography-computed tomography features and literature review 85
Pulmonary Neuroendocrine Tumor Incidentally Detected by 18F-CH PET/CT 84
Groin sentinel node biopsy and18F-FDG PET/CT-supported preoperative lymph node assessment in cN0 patients with vulvar cancer currently unfit for minimally invasive inguinal surgery: The GroSNaPET study 84
TREATMENT OF NEUROBLASTOMA WITH I-131 METAIODOBENZYLGUANIDINE 82
18F-FDG PET and 18F-FDG PET/CT in Vulvar Cancer: A Systematic Review and Meta-analysis 81
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 80
Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. 80
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study 80
Totale 12.379
Categoria #
all - tutte 66.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020144 0 0 0 0 0 0 0 0 0 0 0 144
2020/20211.255 64 152 46 126 170 77 162 26 142 68 196 26
2021/20221.391 125 124 11 98 103 48 29 212 71 65 204 301
2022/20233.339 393 460 202 564 181 421 168 297 393 58 117 85
2023/20241.410 77 430 43 64 44 206 46 68 23 87 168 154
2024/20252.917 80 75 256 121 326 150 158 205 550 313 637 46
Totale 15.975